What is the protocol for cross-tapering from Citalopram to Trazodone?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: April 14, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Research

A cross-taper from citalopram to Trintellix (vortioxetine) should be done gradually over 2-4 weeks under medical supervision. Begin by maintaining your current citalopram dose while starting Trintellix at 5 mg daily. After one week, reduce citalopram by 50% while increasing Trintellix to 10 mg daily (the typical target dose). Continue this reduced citalopram dose for another week, then decrease it by half again while maintaining Trintellix at 10 mg. After another week, discontinue citalopram completely while continuing Trintellix. This gradual approach minimizes discontinuation symptoms from citalopram while allowing your body to adjust to Trintellix. The cross-taper method works because both medications affect serotonin, but Trintellix has additional mechanisms of action, as shown in a study comparing vortioxetine to escitalopram 1.

During this transition, watch for side effects like nausea (common with Trintellix), headaches, dizziness, or mood changes. Stay well-hydrated and maintain regular sleep patterns. Contact your doctor immediately if you experience severe side effects, worsening depression, or unusual thoughts. Never adjust this schedule without consulting your healthcare provider, as individual factors may require personalized adjustments. It's also important to note that vortioxetine has been shown to have a unique receptor-binding profile, including a high affinity for 5-HT7R antagonism, which may contribute to its therapeutic effects 2. Additionally, studies have demonstrated that vortioxetine is effective in treating major depressive disorder, with a likelihood to be helped or harmed (LHH) value of 5.1, indicating that it is 5.1 times more likely to be associated with response than discontinuation due to an adverse event 3.

Some key points to consider during the cross-taper process include:

  • Monitoring for side effects and adjusting the dose as needed
  • Maintaining regular follow-up appointments with your healthcare provider
  • Being patient and allowing your body to adjust to the new medication
  • Notifying your doctor of any changes in your symptoms or overall health. It's crucial to follow the guidance of your healthcare provider and not to adjust the cross-taper schedule without their consultation, as this can impact the effectiveness and safety of the transition.

Related Questions

What is the recommended protocol for switching from sertraline (Zoloft) to vortioxetine (Trintellix)?
Is Trintellix (vortioxetine) compatible with Lexapro (escitalopram)?
How to manage a 7% residual symptom rate in patients after treatment?
What health advice and recommendations are suitable for a 20-year-old?
Which is safer, AER or ZPA?
What is the laboratory workup for irregular menstrual cycles (oligomenorrhea or polymenorrhea)?
What are the causes of left-sided headache (cephalgia) with pressure upon waking, accompanied by intermittent daily headaches?
What is the diagnosis for a patient with hyponatremia (sodium level of 135), hyperglycemia (glucose level of 200), hypochloremia (chloride level of 97), mildly elevated total bilirubin (1.8), leukocytosis (white blood cell (WBC) count of 11.5), normal hematocrit (46.7), elevated segmented neutrophil absolute (seg neut abso) count (1.1), glycosuria (urine glucose of 250), ketonuria (ketones in urine of 15), proteinuria (protein in urine of 100), pyuria (WBC in urine of 6-10), bacteriuria (few bacteria), and granular casts (0-2) in the urinalysis?
Is it common for a 20-year-old autistic female, taking Lexapro (escitalopram) and Tandospirone (sedative anxiolytic), to experience waves of sadness, depression, and mood fluctuations during the luteal phase, and can Selective Serotonin Reuptake Inhibitor (SSRI) intake exacerbate mood and anxiety symptoms?
What are the implications of low prolactin (hypoprolactinemia) levels?
A 17-year-old female presents with central chest pain that has migrated to the right of the sternum, lasting 10 minutes to hours, worsening with forward bending, and unrelieved by Acetylsalicylic Acid (ASA), Tylenol (acetaminophen), or Ibuprofen, with a history of fibromyalgia?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.